Since the resistance was broken, the stock should continue to move upwards.
Moreover, I can't find any stock right now with successful phase 3 trials that is so cheap as OMER.
Maxim sees $300 million sales potential for OMS302 (eye surgery) - http://www.seekingalpha.com/article/1153471-maxim-group-sees-350-upside-in-shares-of-omeros-corporation
Wedbush sees $600 million sales. Currently, market cup is only $148M. The stock should double from this here through the NDA filling and until the final approval. Good luck.